Aleor Dermaceuticals receives USFDA Final Approval for Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation) Posted On: 2021-03-03 22:30:36 (Time Zone: Arizona, USA) Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation). The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), AndroGel 1.62%, of AbbVie Inc. (AbbVie...